GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Accumulated other comprehensive income (loss)

IMGT (XKRX:456570) Accumulated other comprehensive income (loss) : ₩0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. IMGT's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was ₩0.00 Mil.

IMGT Accumulated other comprehensive income (loss) Historical Data

The historical data trend for IMGT's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Accumulated other comprehensive income (loss) Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
- - - -

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss) - - - -

IMGT Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

IMGT Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of IMGT's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XKRX:032790 XKRX:225220 XKRX:298060 XKRX:373110 XKRX:168330 XKRX:142760 XKRX:388610 XKRX:216400 XKRX:446440 XKRX:389030 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines